Tag: regulation

Recent developments in 340B program litigation impact contract pharmacy arrangements and drug manufacturers nationwide with new court rulings.

A federal court upheld agency discretion in drug origin rulings under the Trade Agreements Act, setting key legal precedent for pharmaceutical contracts.

The FDA rejects a hearing request regarding the ban on Red No. 3. The agency finalizes its order to revoke authorizations for the food and drug dye.

The USPTO aims to reduce the PCT backlog through a new mandatory PIER Pilot Program targeting national stage application examination pendency.

TCPA texts are now exempt from the act’s do‑not‑call ban after the Seventh Circuit’s landmark ruling, reshaping bulk‑text litigation and offering new compliance

Illinois to ban certain cosmetic ingredients starting July 2028 under new law, affecting companies' formulations and sales practices.

US and UK issue joint sanctions guidance to implement various sanctions programs effectively.

The EEOC voted to end decades-old workforce reporting rules, reshaping federal employment compliance if finalized. Learn the impact on employers.

Microplastics in everyday products face stricter EPA regulations, increasing compliance costs and litigation risks for businesses.

Colorado’s new recycling law faces a major legal challenge from wholesalers, seeking to block enforcement in federal court.